Heterologous prime-boost vaccination

被引：374

作者：

Lu, Shan ^{[1
,2
,3
]}

机构：

[1] Nanjing Med Univ, Affiliated Hosp 1, China US Vaccine Res Ctr, Nanjing 210029, Peoples R China

[2] Nanjing Med Univ, Affiliated Hosp 1, Dept Infect Dis, Nanjing 210029, Peoples R China

[3] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA

来源：

CURRENT OPINION IN IMMUNOLOGY | 2009年 / 21卷 / 03期

关键词：

HUMAN-IMMUNODEFICIENCY-VIRUS; CELLULAR IMMUNE-RESPONSES; DNA PRIME; NEUTRALIZING ANTIBODIES; GP120; PROTEIN; RHESUS MACAQUES; COMBINATION DNA; SUBTYPE-B; IMMUNOGENICITY; PROTECTION;

D O I：

10.1016/j.coi.2009.05.016

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

071005 [微生物学]; 100108 [医学免疫学];

摘要：

An effective vaccine usually requires more than one time immunization in the form of prime-boost. Traditionally the same vaccines are given multiple times as homologous boosts. New findings suggested that prime-boost can be done with different types of vaccines containing the same antigens. In many cases such heterologous prime-boost can be more immunogenic than homologous prime-boost. Heterologous prime-boost represents a new way of immunization and will stimulate better understanding on the immunological basis of vaccines.

引用

页码：346 / 351

页数：6

共 39 条

[1]

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].

Amara, RR ;

Villinger, F ;

Altman, JD ;

Lydy, SL ;

O'Neil, SP ;

Staprans, SI ;

Montefiori, DC ;

Xu, Y ;

Herndon, JG ;

Wyatt, LS ;

Candido, MA ;

Kozyr, NL ;

Earl, PL ;

Smith, JM ;

Ma, HL ;

Grimm, BD ;

Hulsey, ML ;

Miller, J ;

McClure, HM ;

McNicholl, JM ;

Moss, B ;

Robinson, HL .

SCIENCE, 2001, 292 (5514) :69-74

[2]

Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration [J].

Bansal, Anju ;

Jackson, Bethany ;

West, Kim ;

Wang, Shixia ;

Lu, Shan ;

Kennedy, Jeffrey S. ;

Goepfert, Paul A. .

JOURNAL OF VIROLOGY, 2008, 82 (13) :6458-6469

[3]

Vaccination with HIV 1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit [J].

Barnett, SW ;

Rajasekar, S ;

Legg, H ;

Doe, B ;

Fuller, DH ;

Haynes, JR ;

Walker, CM ;

Steimer, KS .

VACCINE, 1997, 15 (08) :869-873

[4]

Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines [J].

Barouch, DH ;

McKay, PF ;

Sumida, SM ;

Santra, S ;

Jackson, SS ;

Gorgone, DA ;

Lifton, MA ;

Chakrabarti, BK ;

Xu, L ;

Nabel, GJ ;

Letvin, NL .

JOURNAL OF VIROLOGY, 2003, 77 (16) :8729-8735

[5]

Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1 [J].

Beddows, S ;

Schülke, N ;

Kirschner, M ;

Barnes, K ;

Franti, M ;

Michael, E ;

Ketas, T ;

Sanders, RW ;

Maddon, PJ ;

Olson, WC ;

Moore, JP .

JOURNAL OF VIROLOGY, 2005, 79 (14) :8812-8827

[6]

Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine [J].

Biswas, S ;

Reddy, GS ;

Srinivasan, VA ;

Rangarajan, PN .

HUMAN GENE THERAPY, 2001, 12 (15) :1917-1922

[7]

A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge [J].

Cai, H. ;

Yu, D. H. ;

Hu, X. D. ;

Li, S. X. ;

Zhu, Y. X. .

DNA AND CELL BIOLOGY, 2006, 25 (08) :438-447

[8]

A DNA prime-modified vaccinia virus Ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge [J].

Dunachie, S. J. ;

Walther, M. ;

Epstein, J. E. ;

Keating, S. . ;

Berthoud, T. ;

Andrews, L. ;

Andersen, R. F. ;

Bejon, P. ;

Goonetilleke, N. ;

Poulton, I. ;

Webster, D. P. ;

Butcher, G. ;

Watkins, K. ;

Sinden, R. E. ;

Levine, G. L. ;

Richie, T. L. ;

Schneider, J. ;

Kaslow, D. ;

Gilbert, S. C. ;

Carucci, D. J. ;

Hill, A. V. S. .

INFECTION AND IMMUNITY, 2006, 74 (10) :5933-5942

[9]

Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus [J].

Egan, MA ;

Chong, SY ;

Megati, S ;

Montefiori, DC ;

Rose, NF ;

Boyer, JD ;

Sidhu, MK ;

Quiroz, J ;

Rosati, M ;

Schadeck, EB ;

Pavlakis, GN ;

Weiner, DB ;

Rose, JK ;

Israel, ZR ;

Udem, SA ;

Eldridge, JH .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2005, 21 (07) :629-643

[10]

PRIMING FOR AND INDUCTION OF ANTI-POLIOVIRUS NEUTRALIZING ANTIBODIES BY SYNTHETIC PEPTIDES [J].

EMINI, EA ;

JAMESON, BA ;

WIMMER, E .

NATURE, 1983, 304 (5928) :699-703

← 1 2 3 4 →